In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 271 to 280 of 427

TitleTypeExpected publication date
Otilimab for treating moderate to severe rheumatoid arthritis [ID6171]Technology appraisal guidanceTBC
Ovarian cancer QS updateQuality standard
Overweight and obesity managementNICE guidelineTBC
Oxybutynin hydrochloride for managing neurogenic detrusor overactivity in people 6 years and over with spinal cord injury or spina bifida [ID5089]Technology appraisal guidanceTBC
Palforzia for treating peanut allergy in children aged 1 to 3 [ID6144]Technology appraisal guidanceTBC
Palopegteriparatide for treating chronic hypoparathyroidism [ID6380]Technology appraisal guidance
Palovarotene for preventing heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID3739]Highly specialised technologyTBC
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]Highly specialised technologyTBC
Parsaclisib for treating relapsed or refractory marginal zone lymphoma [ID3976]Technology appraisal guidanceTBC
Peezy Midstream for urine collection (MT446)Medical technologies guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All